ood morning, everyone, and how are you today? We are doing just fine, thank you, despite a spot of rain descending on the Pharmalot campus. After all, as the Morning Mayor taught us, “Every brand new day should be unwrapped like a precious gift.” So while you tug on the ribbon, please join us for a cup of stimulation. As always, here are some tidbits. Hope you conquer the world and please do keep in touch …

So how did Dr. Scott Gottlieb, who has been nominated to head the Food and Drug Administration, do during his Senate testimony? By most accounts, he parried questions deftly and looks to win the job, especially since he appears to be a more mainstream choice compared to some other names that were floated. But brand-name drug makers likely noted some warning signs as he indicated he favors steps to speed approvals of generics and biosimilars.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy